Bcl-w is a newly described cell death suppressor member of the Bcl-2 gene family. As these genes may have a role in the outcome of ischemic brain injury. the regional ex pression of Bcl-w protein in rat brain was examined at 6 to 72 hours after 90 minutes of transient middle cerebral artery oc clusion. Bcl-w protein. although constitutively expressed at low levels in nonischemic brain. was found to be overexpressed in ischemic brain at all time points studied. Up-regulation of Bcl-w protein was particularly abundant in the penumbral re gion of the cortex and mainly in cells lacking DNA fragmen tation. In the cortical penumbra. Bcl-w protein was detected predominantly in neurons and showed mitochondrial localiza tion, as determined using double-label immunohistochemistry. Bcl-w expression was also detectable. to a lesser extent. in reactive astrocytes in the infarct border zone and in microvessel Brain injury resulting from cerebral ischemia is a com plex process involving mixed types of cell death. Whereas ischemic neurons often die from necrosis, a significant number of neurons exhibit a type of death reminiscent of apoptosis, in which the genetic program of apoptosis, or programmed cell death, is activated (for reviews, see Choi, 1996; Schulz et aI., 1999). In strong support of a role for apoptosis in ischemic brain injury, Abbreviations used: BH, Bc1-2 homology-binding domain; GST, glutathione S-transferase; MCA, middle cerebral artery; PBS, phos phate-huffered saline.
walls in the infarct regions. At the mechanistic level. incubation of isolated brain mitochondria with the addition of recombinant Bax or high concentration of calcium resulted in release of cytochrome c from the mitochondria. In the presence of recom binant Bcl-w protein. however, the release of cytochrome c induced by Bax or calcium was largely inhibited. Further, re combinant Bcl-w protein inhibited calcium-induced loss of mi tochondrial transmembrane potential, indicative of permeabil ity transition, in a dose-dependent manner. These results sug gest that Bcl-w may be an endogenous neuroprotectant against ischemic neuronal death and that, like its analogues such as Bcl-2 and Bcl-x-long, Bcl-w may achieve this protection via the mitochondrial death-regulatory pathway. Key Words: Ce rebral ischemia-Neuronal apoptosis-Bcl-w-Mitochondrial permeability transition-Cytochrome c. several apoptosis-regulatory genes have recently been found to be activated in neurons after ischemia (Krajew ski et aI., 1995; Chen et aI., 1995 Chen et aI., , 1996 Chen et aI., , 1998a Ni et aI., 1997; Namura et aI., 1998) .
Recent studies on basic mechanisms of apoptosis have established a central paradigm in which a group of cys teine proteases, known as caspases, are responsible for the execution of the death program (for review, see Thornberry and Lazebnik, 1998) . A number of death regulators play important roles in the initiation and regu lation of caspase activation. Of these, the Bc1-2 family of death-modulatory genes, which now has at least 16 iden tified members, is prominent (for review, see Adams and Cory, 1998) . This gene family contains both pro-and antiapoptotic members, with the antiapoptotic Bc1-2 and the proapoptotic Bax the best-studied examples. Bc1-2 family proteins share structural homology in the Bcl-2 homology-binding domains (BH I to 4), which are im portant for their functions as well as for protein interac tions among the family members (Yin et aI., 1994; Cheng et aI., 1996; Wang et aI., 1996; Chittenden et aI., 1995; Hunter et aI., 1996) . Functionally, Bel-2 family proteins such as Bel-2, Bel-X L , Bax, and Bid regulate apoptosis through the mitochondria by controlling mito chondrial membrane permeability and the release of caspase-activating factors (for review, see Green and Reed, 1998) . Among these gene products, Bel-2 and Bax have been shown to be regulated by ischemia (Krajewski et aI., 1995; Chen et aI. 1995 Chen et aI. , 1996 , and modulation of Bel-2 gene expression affects the outcome of ischemic injury (Martinou et aI., 1994; Linnik et aI., 1995; Lawrence et aI., 1996) . Thus, certain Bel-2 family pro teins may be important modulators of neuronal death in ischemia.
The elosest homologues of Bel-2 are Bel-x L and the recently identified antiapoptotic gene Bel-w (Gibson et aI., 1996) . Bel-w is highly conserved from mouse to human, with 99% homology at the amino acid level. Further, there is a 46% homology of Bel-w to Bel-2 (a comparable homology is that of Bel-X L and Bel-2 at 42%) (Gibson et aI., 1996) . Structurally, Bc1-w contains each of the four BH domains and the hydrophobic C terminal transmembrane domain. These properties deter mine that Bel-w is a membrane-bound protein and is able to heterodimerize with a number of proapoptotic Bel-2 family proteins (O'Connor et aI., 1998; Holmgreen et aI., 1999) . A death suppressor action of Bel-w has been dem onstrated by its inhibition of apoptosis in hematopoietic cell lines induced by various apoptosis inducers (O'Connor et aI., 1998; Holmgreen et aI., 1999; Hsu et aI., 1998) .
Bel-w is widely expressed in mammalian tissues in eluding the central nervous system (Print et aI., 1998) . Expression of Bel-w is increased during brain develop ment, with the highest levels in the mature brain (Ham ner et aI., 1999) . However, inactivation of Bel-w by ho mologous recombination in mouse embryonic stem cells produces animals that are normal in brain development presumably due to the redundant function of other anti apoptotic genes (Print et aI., 1998) . These observations suggest that Bel-w may play an important role in mature brain rather than during brain development. Neverthe less, the functional role of Bel-w in the brain, especially in settings of stress, is unexplored. Accordingly, in the present study, we examined the expression of Bel-w pro tein in the rat model of transient cerebral ischemia and investigated the functions of Bel-w in isolated brain mi tochondria.
METHODS

Surgical procedures
All experiments were performed on male Sprague-Dawley rats, each weighing 275 to 300 g. Focal cerebral ischemia was induced in rats by reversible occlusion of the middle cerebral artery (MCA), as previously described (Chen et aI., 1996 (Chen et aI., , 1997 . In brief, anesthesia was induced with 4% isoflurane through a facemask; rats were then intubated and ventilated with 1.5% isoflurane in an air/oxygen mixture (90:8.5%). Blood pressure, blood gases, and blood glucose concentration were maintained in the normal range throughout the experi ments. Temporalis muscle and rectal temperatures were main tained in the range of 36.5 to 37.5DC using a heating pad and a temperature-regulated heating lamp. The bifurcation of the common carotid artery was exposed under the operating mi croscope, the external carotid artery was dissected and coagu lated distally, and the internal carotid artery was isolated and separated from the vagus nerve. A 3-0 monofilament nylon suture (Ethicon, Somerville, NJ, U.S.A.) was introduced into the internal carotid artery through the stump of the external carotid artery and gently advanced for a distance of 20 mm from the common carotid artery bifurcation to block the origin of the MCA for 90 minutes. The MCA blood flow was restored by withdrawing the intraluminal suture from the internal ca rotid artery. Six rats served as sham-operated controls in which animals underwent the same surgical procedures but no suture was inserted. Three normal untreated rats served as naive con trols.
Western blot analysis
The rats were killed at 6, 24, or 72 hours after the completion of ischemia (n = 3-4/experimental condition) or 24 hours after sham operation by lethal overdose with intraperitoneal inj ec tion of 8% chloral hydrate. The brains were rapidly removed; the cortex and caudate putamen ipsilateral and contralateral to the ischemic hemisphere were separately dissected, homog enized, and lysed (Chen et aI., 1996) . The Iysates were cleared by centrifugation at 14,000 g for 30 minutes at 4 ce. The protein was denatured in sodium dodecyl sulfate gel-loading buffer (100 mmollL Tris-HCI, 200 mmollL dithiothreitol, 4% sodium dodecyl sulfate, 0.2% bromophenol blue, and 20% glycerol) at 100DC for 6 minutes and then separated on 12% sodium do decyl sulfate polyacrylamide gels (40 j.1g of protein/sample). Immunoblotting was performed as previously described (Chen et aI., 1996) using a chemiluminescent detection system (Clon tech, Palo Alto, CA, U.S.A.). The antibody used to detect rat Bcl-w is a rabbit polyclonal antibody raised against the Bcl-w recombinant protein (StressGene, Victoria, British Columbia, Canada). The working dilution for Bcl-w in the present study was I :500. Immunoreactivity for Bcl-w on each individual lane of the blots was semi quantified using a gel densitometric scan ning program (Chen et aI., 1998b) .
Immunohistochemistry
Rats were anesthetized with 8% chloral hydrate at 0, 1.5, 3, 6, 16, 24, or 72 hours after 90 minutes of ischemia or 24 hours after sham operation (n = 4/time point) and then perfused with 200 mL of heparinized 0.9% saline followed by 500 mL of 4% paraformaldehyde in 0.1 mollL phosphate-buffered saline (PBS; pH 7.4). The brains were removed, immersed in 4% paraformaldehyde for 4 hours, and then placed in 30% sucrose at 4DC for 3 days before they were snap-frozen in 2-methylbu tane at -30DC. Brains were cut into 15-j.1m-thick coronal sec tions using a cryostat, mounted, and kept at -80GC until use. Sections at the levels of midcaudate (anteroposterior = +0.2 mm from bregma) were processed for immunohistochemical staining. The sections were air-dried and then washed three times with PBS. After the sections were permeabilized with 2.0% Triton X-IOO for 30 minutes followed by three PBS washes, they were incubated in PBS containing 0.5% bovine serum albumin and 2% normal goat serum for 20 minutes to reduce nonspecific activity. Sections were then incubated for 2 hours at room temperature at I :200 dilution in the same Bcl-w antibody used for western blot analysis. Sections were washed in PBS three times for 10 minutes each and then incubated for 2 hours at room temperature at a I :3,000 dilution with goat anti-rabbit Cy3.18 immunoconjugate (Jackson Immunochemi cals, West Grove, PA, U.S.A.). This was followed by incuba tion of the sections in the nuclear DNA dye Hoechst 33258 at 10 ILg/mL for 5 minutes. Sections were then washed in PBS four times for 15 minutes each on an orbital shaker, mounted in Gelvatol, and coverslipped. A Zeiss light microscope equipped for epit1uorescent illumination was used for observation. For the assessment of nonspecific immunostaining, alternating sec tions from selective experimental conditions (24 hours after ischemia) were incubated without the primary antibody or with the Bcl-w antibody that was reabsorbed with the rat Bcl-w recombinant protein at the concentration of 10 ILg/mL.
To confirm ischemic infarction and neuronal death in this animal model, brain sections obtained at 24 and 72 hours after ischemia (n = 4/group) were stained with cresyl violet.
Double-label immunohistochemistry
To determine if Bcl-w protein is associated with the mito chondrial membrane in ischemic brains, double-label immuno histochemistry for Bcl-w and the mitochondrial membrane bound protein cytochrome c oxidase IV was performed in sec tions obtained 6 and 24 hours after ischemia (n = 3ltime point). The sections were first processed for Bcl-w immuno histochemistry as described above and then incubated for 2 hours at room temperature with a monoclonal antibody against cytochrome c oxidase IV (Molecular Probes, Eugene, OR, U.S.A.) at a dilution of 1:3,000. After three PBS washes, the sections were incubated at room temperature for 1 hour with a horse anti-mouse t1uorescein isothiocyanatelt1uorescein immu noconjugate (Vector Laboratories, Burlingame, CA, U.S.A.).
To identify the cell types in which Bcl-w protein is expressed after ischemia, double-label immunohistochemistry was per formed for Bcl-w and either the neuronal nuclear marker NeuN (Chemicon International, Temecula, CA, U.S.A.) (Liu and Fer enci, 1998) or the glial marker glial fibrillary acidic protein (Sigma, St. Louis, MO, U.S.A.) (Chen et aI., 1997) was used. The procedures were essentially the same as described above.
Detection of DNA fragmentation and double staining
In situ detection of DNA fragmentation (as a marker for cell death) in ischemic brains was performed using the large frag ment of DNA polymerase I, as previously described (Chen et aI., 1998b) . The reaction mixture contained 5 mmollL MgC12, 5 mmol/L 2-mercaptoethanol, 20 ILg/mL bovine serum albu min, 10 ILmollL each of dGTP, dCTP, dTTP, and biotiny1ated dATP, and 30 U/mL large fragment of DNA polymerase I (Sigma) in PBS (pH 7.4). The reaction was terminated by washing the sections three times in PBS. The incorporated biotinylated dATP in damaged DNA was detected using t1uo rescein isothiocyanate/avidin D (cell-sorting grade; Vector Laboratories), which selectively binds to biotin and produces a green-yellow color under fluorescent microscopy.
To determine if Bcl-w protein is expressed in the same cells that contain DNA fragmentation after ischemia, double staining for Bcl-w immunohistochemistry and DNA damage labeling was performed in brain sections obtained 24 and 72 hours after ischemia (n = 3/time point). Brain sections were first pro cessed for Bcl-w immunohistochemistry, as described above. After washes in PBS for I hour, the sections were then sub jected to labeling for DNA fragmentation using the method described above. Sections were examined by fluorescence mi croscopy using excitation/emission wavelengths of 550/565 To study the in vitro effect on mitochondria by Bcl-w, a cDNA encoding the whole reading frame of Bel-w was isolated from rat brain using polymerase chain reaction. Polyadenylated mRNAs were isolated from the rat cerebral cortex using a fast track mRNA isolation kit (Invitrogen, San Diego, CA, U,S,A.) and were used as templates for cDNA synthesis, as described (Chen et aI., 1998a) . Polymerase chain reaction was performed using primers designed according to the Bel-w sequence pre viously reported (Hamner et aI., 1999) : 5' -TCACTTGCTAGC AAAAAAGGCCCC-3' (antisense) and 5'-ATGGCGACCCC AGCCTCAACCCC-3' (sense), The products generated from polymerase chain reaction were subcloned into pSPORT l vec tor (GibcoBRL, Grand Island, NY, U.S.A,), amplified, purified, and subjected to sequencing analysis (University of Pittsburgh Service Core Facility),
To generate Bel-w fusion protein, the Bcl-w cDNA was amplified using the primers 5'-GCCGCCACCATGGCGAC CCCAGC-3' (sense) and 5'-TCACTTGCTAGCAAAAAAG GCCCC-3' (antisense). The cDNA was fused into the glutathi one S-transferase (GST) gene in PGEX-2T vector according to the manufacturer's instructions (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, England), The GST-Bel-w fusion protein was expressed in Escherichia coli BL2 1 cells and absorbed to a glutathione-Sepharose 4B column, The fu sion protein was further cleaved by incubation in thrombin protease for 16 hours at room temperature. The eluate was collected by centrifugation at 500 g for 5 minutes at 4°C. The purified Bel-w protein was verified by western blot analysis.
A GST-Bax fusion protein was also generated and purified using the method described above. The cDNA for expressing Bax fusion protein is a truncated human Bax that lacks the 21-amino acid hydrophobic C-terminus but retains the function (Yin et aI., 1994) .
In vitro effect of Bcl-w on isolated mitochondria It has been proposed that the mitochondrion is the central site for the regulation of apoptosis by Bcl-2 family proteins, Whereas proapoptotic proteins such as Bax and Bak induce mitochondrial permeability transition and cytochrome c re lease, antiapoptotic proteins such as Bel-2 and Bcl-x L inhibit these changes (Narita et aI., 1998; Jurgensmeier et aI., 1998; Eskes et aI., 1998) , To determine if Bel-w possesses the ability to protect mitochondria as Bel-2 and Bel-XL do, the in vitro effect of Bel-w on isolated brain mitochondria was studied.
Mitochondria were purified from normal nonischemic rat brain, as previously described (Berman and Hastings, 1999) , Mitochondria were suspended at 10 mg of protein/mL in the MSB buffer containing 400 mmol/L mannitol, 50 mmollL Tris HCI (pH 7.2), 5 mg/ml bovine serum albumin, and 10 mmol/L KH2P04 and kept on ice for up to 4 hours (Jurgensmeier et aI., 1998) .
For the cytochrome c release assay, mitochondria (1 mg of protein/mL) were incubated with recombinant Bax (50 ILg/mL) or 100 ILmollL Ca 2 + in the presence or absence of recombinant Bcl-w (50 or 250 ILg/mL) in the MSB buffer for I hour. Mi tochondria were pelleted by centrifugation and subjected to immunob10tting with antibodies to Bax (Santa Cruz Biotech nology, Santa Cruz, CA, U,S.A,) or Bcl-w (StressGene), The resulting supernatants were analyzed by immunoblotting with a monoclonal antibody against cytochrome c (Pharmingen, San Diego, CA, U,S.A.), For the measurement of mitochondrial permeability transi tion, mitochondria (1 mg of protein/mL) were incubated with 100 f-lmo11L Ca 2 + in the presence or absence of recombinant Bel-w (50 to 500 f-lg/mL) or cyelosporin A (I to 10 f-lmo11L) for 30 minutes. Mitochondrial transmembrane potential (L�W) was analyzed by measuring the �W-dependent uptake of rhoda mine-123, as previously described (Narita et aI., 1998; Marzo et aI., 1998) . Fluorescence was determined in a Millipore (Bed ford, MA, U.S.A.) CytoFluor 2300 automated plate-reading t1uorometer with excitation at 505 nm and emission at 534 nm.
RESULTS
Western blot analysis
Western blotting revealed the presence of BcI-w im munoreactivity in both cortex and caudate putamen samples from sham-operated brains. The levels of BcI-w protein expression were increased four-to sixfold in the cortex from 6 to 72 hours after 90 minutes of MCA occlusion with a maximum concentration seen in the 72-hour time point (Fig. 1 ). In the caudate putamen, the increase was approximately twofold, with the maximum concentration occurring at 24 hours.
Immunohistochemistry
Immunohistochemical identification of BcI-w protein was performed on brain sections using indirect immuno fluorescence with double labeling with the DNA dye Hoechst 33258. In normal nonischemic brains, Bel-w immunoreactivity was detectable at low levels in neurons throughout most forebrain regions, including cortex, cau-date putamen, thalamus, and hippocampus. As shown in the top of Fig. 2A , the localization of BcI-w immunore activity was distinct from the Hoechst 33258 staining and exclusively in the cytoplasm. BcI-w immunoreactiv ity was increased in both cortex and caudate putamen beginning at 6 hours and peaking at 24 hours after tran sient focal ischemia (Fig. 2 bottom, B and F) . The in creased immunoreactivity of Bel-w had a punctate ap pearance, suggesting a membrane-bound rather than a soluble protein. Although not all neurons showed promi nent BcI-w up-regulation with ischemia, in many cells the expression was robust, especially in the cortical pen umbra 24 and 72 hours after ischemia (Fig. 2 top, C and D). Penumbral expression of Bel-w was at all time points more prominent than that in the ischemic core region of caudate putamen (Fig. 2 top, F to H) . Sections that were incubated without the primary antibody or with the pri mary antibody reabsorbed with the recombinant Bel-w protein showed background fluorescence only (data not shown).
Double-label immunohistochemistry
Subcellular localization of Bel-w immunoreactivity in neurons was studied using double-label immunohisto chemistry with the mitochondrial membrane-bound en zyme cytochrome c oxidase. The punctate membrane bound features of BcI-w immunoreactivity in ischemic neurons, seen in the bottom panels of Fig. 2 tion. To confirm the mitochondrial localization of Bcl-w, mitochondrial protein extracts were prepared from cor tices of sham-operated brains and brains subjected to 90 minutes of MeA occlusion followed by 24 or 72 hours of reperfusion (n = 3/condition) and subjected to western blot analysis for Bcl-w. The western blot showed in creased Bcl-w contents in the mitochondrial fraction af ter ischemia (Fig. 3) . Double-label immunohistochemistry of Bcl-w with neuronal and glial markers in brains obtained 24 or 72 hours after ischemia is shown in Fig. 4 . In the ischemic cortex, especially the penumbral regions, Bcl-w immu- noreactivity was predominantly distributed in cells that were stained positively with the neuronal nuclear marker NeuN (Figs. 4A to 4C ). In the cortical infarct border zone, Bcl-w expression was also seen in scattered glial fibrillary acidic protein-stained cells. These Bcl-w positive astrocytes showed thick and extended processes with morphology suggesting a reactive state (Figs. 4D to 41) . It was frequently seen in the infarct border that a few surviving neurons were surrounded by reactive astro cytes (Fig. 4K ). In the infarct core regions, Bcl-w protein was also expressed. However, such expression appeared to be limited to vessel walls (Fig. 41) . immunoreactivity in the mitochondrial fraction after ischemia. Mi tochondrial protein was purified from the cortex at 6 or 24 hours after ischemia or 24 hours after sham operation and subjected to western blot analysis. Control western blots show that the purified protein fraction is enriched in the mitochondrial membrane-bound protein cytochrome c oxidase IV (COX-IV) but does not contain the cytosolic protein a-tubulin.
Discordance between Bcl-w expression and
DNA fragmentation
Representative double-label of Bcl-w immunohisto chemistry and DNA damage is shown in Fig. 5 . Positive staining for DNA fragmentation and Bcl-w immunore activity was frequently observed in the same microscopic fields in the cortical infarct border zone 24 and 72 hours after ischemia. However, increased Bcl-w immunoreac tivity was found in cells that did not show DNA damage. Cells that contained DNA damage showed low levels or absence of Bcl-w immunoreactivity.
In vitro effect of Bcl-w Both recombinant rat Bcl-w protein and truncated Bax protein were expressed in E. coli BL21 cells (see Meth ods) and purified (Fig. 6A ). Incubation of mitochondria for 1 hour without the addition of Bax resulted in no release of cytochrome c to the supernatant (Fig. 6B) . Incubation with the addition of recombinant Bax or cal cium resulted in redistribution of cytochrome c from the mitochondria to the supernatant. In the presence of Bcl-w protein, however, the release of cytochrome c induced by Bax or calcium was inhibited. Western blot analysis de tected increased amounts of Bax and Bcl-w in the mito chondrial pellet (Fig. 6C ), suggesting that Bax and Bcl-w were incorporated into the mitochondrial membrane.
As shown in Fig. 6D , recombinant Bcl-w protein in hibited calcium-induced loss of mitochondrial � '1', indi cator of permeability transition, in a dose-dependent manner. Such an effect was also achieved using the mi tochondrial permeability transition pore inhibitor cyclo sporin A, as previously reported (Narita et aI., 1998) .
DISCUSSION
Bcl-w is a newly identified antiapoptotic member of the Bcl-2 gene family that is constitutively expressed in adult brain. The data presented here demonstrate that the expression of Bcl-w protein is up-regulated in the brain after transient focal ischemia. Bcl-w protein is overex pressed predominantly in cells that survive the ischemic insult. This pattern of expression resembles that of Bcl-2 (Chen et aI., 1995) but is opposite from that of the pro apoptotic protein Bax in ischemic brain (Krajewski et aI., 1995; Chen et aI., 1996; Gillardon et aI., 1996) . These results thus support a role for Bcl-w and other antiapop totic Bcl-2 members in promoting cell survival after ce rebral ischemia.
The presence of Bcl-w protein in the cerebral cortex and caudate putamen of sham-operated and ischemic brains was confirmed using western blot analysis. A 21-kDa protein of the expected molecular mass for Bcl-w was found in sham and ischemic cortical and caudate putamen samples. Optical density semiquantification showed a four-to sixfold increase of the protein in the ischemic cortex, with maximum expression at 72 hours. In the caudate putamen, the up-regUlation was only two fold, with a maximum at 24 hours. This pattern of Bcl-w expression in this model is consistent with a survival protein as the caudate putamen infarcts, but the cortex constitutes a penumbral region that largely survives.
The cellular localization of Bcl-w protein was deter mined immunocytochemically in brain sections counter stained with the nuclear DNA dye Hoechst 33258. In sham-operated brains or in the contralateral hemisphere of ischemic brains, Bcl-w immunoreactivity was detect able at low levels in a nonnuclear localization. The in tensity and the number of cells showing this immunore activity were increased in both caudate putamen and cor tex in the ischemic brain beginning at 6 hours after ischemia. The expression was particularly abundant in the cortical penumbra where the immunoreactivity nearly filled the cytoplasmic compartment in some isch emic neurons (Fig. 2 top, B to D) . The expression was much less robust in the ischemic core region of caudate putamen where infarct occurred (Fig. 2 top, F to H) .
The appearance of Bcl-w immunoreactivity was that of a punctate pattern in the cytoplasm of neurons. This pattern of staining suggests that the protein is membrane bound, as the presence of the hydrophobic C-terminal transmembrane domain in the Bcl-w protein would pre dict (Gibson et aI., 1996) . In an attempt to identify the specific cytoplasmic membrane to which Bcl-w was bound, sections were double-stained with the mitochon drial membrane-bound enzyme cytochrome c oxidase. As shown in the bottom panels of Fig. 2 , cytochrome c oxidase immunoreactivity and that of Bcl-w overlapped, strongly suggesting mitochondrial localization for this gene product. The mitochondrial localization of BcI-w was further confirmed using subcellular fractionation followed by western blot analysis (Fig. 3) .
The cell types that exhibited increased BcI-w immu noreactivity were assessed using double-label immuno histochemistry (Fig. 4) . BcI-w immunoreactivity was seen mainly in neurons in the cortical penumbra as most BcI-w-expressing cells were also stained positively for the neuronal marker NeuN. In the cortical infarct border zone, BcI-w expression was also detectable in reactive astrocytes. Within the cortical infarct, however, BcI-w immunoreactivity was seen in the microvessel walls but detectable in few neurons. This is a pattern highly remi niscent of that seen with BcI-2, which is also expressed in focal ischemia in all cell types that survive various degrees of ischemia (Chen et a!., 1995) . In contrast to neurons, BcI-w expression in astrocytes showed a diffuse instead of a punctate pattern (Fig. 4) . The different sub cellular localization in these two different cell types can not be readily explained by the available data. One pos sibility is that the sensitivity of the immunofluorescent method used in this study was insufficient to distinguish cytosolic from mitochondrial immunoreactivity in astro cytes where the cell bodies and processes are much nar rower than neurons. Alternatively, as expression of BcI-w was up-regulated in reactive astrocytes and reac tive astrocytes were maximally detected at 72 hours in this model, translocation of BcI-w from cytosol to the mitochondria may occur at later time points. Future stud ies employing longer duration of reperfusion may ad dress this issue.
The preferential expression of BcI-w in cells that sur vive ischemia was demonstrated in DNA fragmentation/ BcI-w immunohistochemistry double-label experiments in which DNA damage labeling served as a marker of cell death (Chen et a!., 1998a) . Whereas a large number of DNA-fragmented cells were seen in the cortical and caudate putamen infarct zones, very few cells in these areas exhibited BcI-w immunoreactivity. Both DNA damage labeling and increased BcI-w immunoreactivity were frequently seen in the infarct border zone. How ever, there was little overlap between these two labels ( Fig. 5) , indicating that DNA fragmentation developed predominantly in cells that expressed no or a low level of Bcl-w protein. This pattern of staining was opposite from that of the proapoptotic protein Bax, which was previ ously found to be up-regulated in dying neurons after ischemia (Krajewski et a!., 1995; Chen et a!., 1996; Gil lardon et aI., 1996) . Accordingly, such differential ex pression of and Bax in ischemic brain may shift the ratio of antiapoptotic versus proapop totic proteins in surviving and dying cells in opposite fashions. This ratio has been considered to be an impor tant determinant of the fate of cell death in developmen tal as well as in pathological apoptosis Yang and Korsmeyer, 1996) . The up-regUlation of BcI-w expression in survival neurons seen in this study is thus compatible with, but, however, does not prove, a neuroprotective role of BcI-w in the ischemic brain.
The mechanism of presumed neuroprotection by BcI-w cannot be stated with certainty based on the avail able data. However, like several other BcI-2 family members, BcI-w contains the transmembrane C-terminal domain, which allows it to localize to mitochondrial membranes (Gibson et aI., 1996) . Moreover, BcI-w pos sesses the BH 1 to 3 domains that are essential for it to heterodimerize with proapoptotic Bcl-2 family members. Thus, it can be inferred that, like its homologues such as BcI-2 and BcI-x L , BcI-w may regulate apoptosis through the mitochondrial pathway by opposing the effect of pro apoptotic proteins. However, the prosurvival effect by Bcl-w or its homologues may or may not be related to its direct binding to proapoptotic proteins. It has been shown that BcI-w protected against apoptosis induced by overexpression of Bax or Bad but not that induced by
'" -0 <:) CO induced loss of mitochondrial transmembrane potential (D.qr) in isolated brain mitochondria. D.qr was determined by measuring the uptake of rhodamine-123 fluorescence. The protonophore CCCP (10 IJmol/L) served as the positive control (100%) for D. qr loss. Data are means ± SD of three different experiments. * P < 0.05, ** P < 0.01, *** P < 0.0001 versus calcium-treated group without inhibitors (analysis of variance and post hoc Fisher's t tests).
Bak or Bik, although Bel-w was able to heterodimerize with all four proteins (Holmgreen et aI., 1999) . On the other hand, Al protein, a Bel-w homologue, although unable to bind to Bax or Bad, blocked Bax-and Bad induced cytotoxicity (Holmgreen et aI., 1999) . Further more, certain BH mutants of Bel-xL that cannot bind to Bax or certain other proapoptotic proteins retain signifi cant antiapoptotic activity (Cheng et aI., 1996; Kelekar et aI., 1997) . Therefore, alternative mechanisms by which Bel-2 members regulate apoptosis that are independent of protein-protein heterodimerization must exist. One such mechanism that has been proposed is the channel forming activity of these proteins. Both pro-and anti apoptotic Bel-2 members are capable of acting as ion channels in mitochondrial membranes (Antonsson et aI., 1997; Minn et aI., 1997; Schendel et aI., 1997; Schle singer et aI., 1997) , and the functional states of these channels may largely determine the changes in mito chondrial membrane permeability during apoptosis (Green and Reed, 1998) . Therefore, Bel-w may possess the neuroprotective effect through the mitochondrial pathway via multiple mechanisms. Our in vitro data strongly support a role for Bcl-w in regulating cell death through the mitochondria, As shown in Fig. 6 , the recombinant rat Bel-w protein de creased Bax-or Ca 2 +-induced release of cytochrome c from isolated brain mitochondria, Furthermore, Bel-w inhibited Ca 2 + -induced mitochondrial permeability tran-sition in a dose-dependent manner (Fig. 6) , an effect that resembles the mitochondrial permeability transition pore inhibitor cyclosporin A. These findings bear significance in the context of ischemic brain injury. Mitochondrial release of cytochrome c and other apoptosis inducers such as caspase-9 has recently been detected in ischemic neurons (Fujimura et aI., 1998 (Fujimura et aI., , 1999 Krajewski et aI., 1999) , suggesting a role for mitochondrial damage in activating effector caspases. In addition, calcium accu mulation in mitochondria and cyclosporin A-inhibitable mitochondrial permeability transition has been implied in the development of cerebral infarction and delayed death of hippocampal neurons after transient ischemia (Uchino et aI., 1998; Matsumoto et aI., 1999) . Accord ingly, Bcl-w, upon overexpression and translocation to mitochondria, could protect the mitochondria from dam age induced either by proapoptotic proteins or by cal cium accumulation and consequently reduce cell death.
In summary, transient focal ischemia induced the overexpression of the antiapoptotic protein Bcl-w in rat brain. Increased expression of Bcl-w was detected mainly in neurons and other cell types that survived isch emia but not in cells that developed DNA fragmentation. As Bcl-w is a mitochondrial membrane-bound protein and Bcl-w can inhibit mitochondrial damage induced by Bax or calcium in vitro, these results thus support a role for Bcl-w in protecting neurons against ischemia and reperfusion injury via mitochondrial mechanisms. Fur ther investigation is warranted to confirm these effects by Bcl-w in vivo.
